亞虹醫藥(688176.SH):股東自願承諾延長股份鎖定期
格隆匯12月27日丨亞虹醫藥(688176.SH)公佈,近日收到公司股東出具的《關於自願延長限售股鎖定期的承諾函》。基於對公司未來發展前景的信心及投資價值的認可,公司控股股東、實際控制人PANKE先生的一致行動人Pan-ScientificHoldingsCo.,Ltd.、泰州東虹企業管理中心(有限合夥)、泰州亞虹企業管理中心(有限合夥)共計3名股東,承諾將其所持有的公司首次公開發行前的全部股份自2025年1月7日限售期滿之日起自願延長鎖定期6個月至2025年7月6日,承諾鎖定期內,將不以任何方式轉讓、減持或委託他人管理所持有的公司上市前股份,亦不會要求公司回購所持股份。在上述承諾鎖定期內,因公司送紅股、轉增股本、配股等原因而增加的股份,亦將遵守上述延長鎖定期的承諾。上述3名股東在所持股份於2025年7月7日上市流通後,仍需嚴格遵守《上市公司股東減持股份管理暫行辦法》或屆時適用的法律、法規、規範性文件或監管部門、證券交易所關於減持股份的相關規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.